{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:12:27Z","timestamp":1767211947601,"version":"build-2065373602"},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,4,5]],"date-time":"2009-04-05T00:00:00Z","timestamp":1238889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>\n                    A growing percentage of the population is resistant to two key hormones \u2013 insulin and leptin \u2013 as a result of increased obesity, often leading to significant health consequences such as type 2 diabetes. Protein tyrosine phosphatase 1B (PTP1B) is a key negative regulator of signalling by both of these hormones, so that inhibitors of this enzyme may provide promise for correcting endocrine abnormalities in both diabetes and obesity. As with other tyrosine phosphatases, identification of viable drug candidates targeting PTP1B has been elusive because of the nature of its active site. Beginning with novel phosphotyrosine mimetics, we have designed some of the most potent PTP1B inhibitors. However, their highly acidic structures limit intrinsic permeability and pharmacokinetics. Ester prodrugs of these inhibitors improve their drug\u2010like properties with the goal of delivering these nanomolar inhibitors to the cytoplasm of cells within target tissues. In addition to identifying prodrugs that is able to deliver active drugs into cells to inhibit PTP1B and increase insulin signalling, these compounds were further modified to gain a variety of cleavage properties for targeting activity\n                    <jats:italic>in vivo<\/jats:italic>\n                    . One such prodrug candidate improved insulin sensitivity in\n                    <jats:italic>ob\/ob<\/jats:italic>\n                    mice, with lowered fasting blood glucose levels seen in the context of lowered fasting insulin levels following 4\u2003days of intraperitoneal dosing. The results presented in this study highlight the potential for design of orally active drug candidates targeting PTP1B, while also delineating the considerable challenges remaining.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2008.01022.x","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T00:01:45Z","timestamp":1238976105000},"page":"579-588","source":"Crossref","is-referenced-by-count":19,"title":["Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling"],"prefix":"10.1111","volume":"11","author":[{"given":"D. V.","family":"Erbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Klaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.\u2010K.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Kirincich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Will","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/414782a"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)01081-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/414799a"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00149-1"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5407.1544"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.15.5479-5489.2000"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00148-X"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.142298199"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.21"},{"key":"e_1_2_6_11_2","unstructured":"BhanotS ButlerM BootenSet al.Effects of a novel PTP1B antisense inhibitor (ISIS 113715) in cynomolgus monkeys. Diabetes Mellitus: Molecular Mechanisms Genetics and New Therapies Conference: 27 Jan\u20102 Feb Keystone CO USA2002; Abstract 202."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00603-3"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm030629n"},{"key":"e_1_2_6_14_2","first-page":"500","article-title":"Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes","volume":"5","author":"Tobin JF","year":"2002","journal-title":"Curr Opin Drug Discov Devel"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd895"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3923\/ijp.2006.93.97"},{"key":"e_1_2_6_17_2","first-page":"805","article-title":"Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes","volume":"8","author":"Kasibhatla B","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.13420"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm990260v"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.005553"},{"key":"e_1_2_6_21_2","unstructured":"BurkeyBF DongM WennogleLet al.Pharmacogenomic evaluation of a putative orally active PTP\u20101B inhibitor using ob\/ob mice reveals an alternative mechanism of action. 62nd American Diabetes Association Annual Meeting: 14\u201018 June San Francisco CA USA2002; Abstract 138."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2005.11.005"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0702478"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.06.051"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2007.03.032"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005615200"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2006.05.002"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.2174\/138955705774329528"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2.3.419"},{"key":"e_1_2_6_30_2","first-page":"495","article-title":"Application of pharmaceutical profiling assays for optimization of drug\u2010like properties","volume":"8","author":"Di L","year":"2005","journal-title":"Curr Opin Drug Discov Devel"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03383-0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1208\/ps020106"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb803"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9016"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/S0021-9258(18)52289-4","article-title":"Differential regulation of the GLUT\u20101 and GLUT\u20104 glucose transport systems by glucose and insulin in L6 muscle cells in culture","volume":"266","author":"Koivisto U\u2010M","year":"1991","journal-title":"J Biol Chem"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi002865v"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2008.01022.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2008.01022.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:09:57Z","timestamp":1761865797000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2008.01022.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1463-1326.2008.01022.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2008.01022.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2009,5,6]]}}}